53233-90-2

Basic information

• Product Name: methyl 2-methylthiazole-5-carboxylate
• Synonyms: methyl 2-methylthiazole-5-carboxylate;Methyl 2-Methyl-1,3-thiazole-5-carboxylate;5-Thiazolecarboxylic acid, 2-Methyl-, Methyl ester;2-Methyl-thiazole-5-carboxylic acid methyl ester;2-methyl-5-thiazolecarboxylic acid methyl ester;MFCD14635883
• CAS NO: 53233-90-2
• Molecular Formula: C6H7NO2S
• Molecular Weight: 157.19028
• EINECS: -0
• Mol File: 53233-90-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 224.7±13.0 °C(Predicted)
• Appearance: /
• Density: 1.244±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 1.51±0.10(Predicted)
• CAS DataBase Reference: methyl 2-methylthiazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-methylthiazole-5-carboxylate(53233-90-2)
• EPA Substance Registry System: methyl 2-methylthiazole-5-carboxylate(53233-90-2)

Safety Data

• Hazardous Substances Data: 53233-90-2(Hazardous Substances Data)

Usage

Uses

Used in Food Industry:
Methyl 2-methylthiazole-5-carboxylate is used as a flavoring agent for its ability to enhance the aroma of various food products, providing a strong, fruity scent that can improve the overall sensory experience of consumption.
Used in Fragrance Industry:
In the fragrance industry, methyl 2-methylthiazole-5-carboxylate is utilized as an ingredient to contribute to the complex scent profiles of perfumes, colognes, and other scented consumer goods, thanks to its distinctive and pungent odor.
It is crucial to adhere to proper safety guidelines and regulations when incorporating this chemical into products to ensure that it is used safely and does not lead to adverse health effects.

Upstream product

• 67-56-1 methanol 
• 40004-69-1 2-methyl-1,3-thiazole-5-carboxylic acid 
• 20656-61-5 methyl 2-chloro-3-oxopropionate 
• 62-55-5 thioacetamide 

Downstream Products

• 99979-78-9 2-methyl-thiazole-5-carboxylic acid amide 
• 56012-38-5 5-(hydroxymethyl)-2-methylthiazole 

Relevant articles and documents

Synthesis method of 2-(aminomethyl)-1, 3-thiazole-5-carboxylic acid methyl ester

The invention discloses a synthetic method of 2-(aminomethyl)-1, 3-thiazole-5-carboxylic acid methyl ester, and belongs to the technical field of drug intermediate synthesis. According to the synthetic method, 2-methylthiazole-5-carboxylic acid is adopted as an initial raw material and sequentially subjected to classical chemical reactions of esterification, bromination, single reduction, bis-Boc amination and Boc removal to obtain the target compound 2-(aminomethyl)-1, 3-thiazole-5-carboxylic acid methyl ester, wherein the purity is 97% or above, the total yield reaches up to 48.3%, and the stability is good; the problems of low yield, difficulty in purification, large reagent smell, difficulty in obtaining of ring closing raw materials and difficulty in amplification of the whole process in synthesis of similar compounds in the prior art are solved, and application of the target compound in the field of medicines is promoted.

FLUOROALKYL-OXADIAZOLES AND USES THEREOF

Provided herein are compounds identified as inhibitors of HDAC6 activity that can be used to treat various diseases and disorders.

Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, to a process for preparing the compound of formula (I), and to use of the compound of formula (I) or a pharmaceutically acceptable salt or

DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USES IN PREPARATION OF MEDICAMENTS FOR TREATING AND PREVENTING ANTIVIRAL DISEASES

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, to a process for preparing the compound of formula (I), and to use of the compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a medicament, in particular as a medicament for the treatment and prevention of type B hepatitis.